MATERIALS AND METHODS Systematic Review To inform the development of these
guidelines, a systematic review of evidence was performed. We followed the Preferred …

Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …

Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy
involving the systemic administration of a radiolabelled peptide designed to target with high …

Opinion statement The incidence of metastatic pheochromocytoma (PHEO) and
paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and …

This study tested the principle that 68Ga-DOTATATE PET/CT may be used to select children
with primary refractory or relapsed high-risk neuroblastoma for treatment with 177Lu …

Materials and Methods: GaTATE studies (8 patients; 2 to 9 years old) were reviewed and
compared with 123 I-MIBG or posttreatment 131 I-MIBG studies. Immunohistochemistry …

Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis,
approximately 50% of patients present with metastatic disease. These patients are at high …

ABSTRACT Objective: Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are
neural crest cell tumors associated with catecholamine production and assessed by a …

At present there is no clinical guideline or standardised protocol for the treatment of
metastatic or invasive phaeochromocytoma and paraganglioma (collectively known as …